
Minister of Health and Welfare Shi Chongliang said that through inter-ministerial cooperation, the dementia diagnosis rate and service coverage rate will be improved, and young patients with dementia will be included in the long-term care 3.0 service targets.
AI-generated summary
Taiwan is entering a super-aging society, and the number of dementia patients is increasing year by year. The uneven distribution of diagnosis and care resources among counties and cities has aroused concern from relevant associations.
Taiwan is facing the threat of super-aging and the population with dementia is also increasing year by year. The Taiwan Dementia Association is worried that there is currently a significant gap in dementia diagnosis and care resources among counties and cities. In this regard, Minister of Health and Welfare Shi Chongliang said that although the dementia care resources, promotion process, and degree of aging vary among counties and cities, the Ministry of Health and Welfare will cooperate with inter-ministerial committees through the four major directions of the action plan to jointly promote measures related to dementia patients.
The Taiwan Dementia Association pointed out that there are significant differences in the size of the dementia population and the ratio of diagnostic care services faced by counties and cities. Areas with relatively low diagnostic care service ratios should further examine early identification, medical guidance, service accessibility, resource capacity and actual family use experience to identify service gaps and propose improvement measures.
Shi Chongliang said that the Ministry of Health and Welfare will promote the "Dementia Prevention and Care Policy Framework and Action Plan 3.0" starting from 2026, including four directions: accurate diagnosis and treatment, daily care, prevention and protection of the rights and interests of people with dementia. It also proposed to achieve the goal of "Dementia Friendly Taiwan 888" by 2035, including the rate of accurate diagnosis of dementia, the coverage rate of dementia services, and the dementia literacy rate of personnel in specific institutions or fields reaching 80%.
Regarding accurate diagnosis and treatment, Shi Chongliang pointed out that the development of drugs for the treatment of dementia is the future trend. However, in the past, most dementia relied on clinical symptom judgment, and the diagnosis of the cause was not so accurate. In the future, he hopes to help patients control the disease through accurate diagnosis and accurate treatment, coupled with corresponding payment plans.
Shi Chongliang also mentioned that the government has expanded care for patients with dementia. Long-term care 3.0 has included young patients with dementia as service targets and provided necessary assistance based on grading. In the future, it will continue to expand capacity such as group homes and small-scale multi-functional services (small-scale machines).
In addition, Shi Chongliang said that in the future, the Ministry of Health and Welfare will also promote "social prescription" through policies such as health coins, and combine it with the policies of the Ministry of Sports, the Ministry of Culture, and the Ministry of Education to prevent or delay the progression of dementia. It will also protect the rights and interests of people with dementia through cross-ministerial cooperation and provide comprehensive protection for patients with dementia.
AI outlook — possibilities, not facts
Launch the Dementia Prevention, Treatment and Care Policy Framework and Action Plan 3.0 in 2026
Very likely · Within years

iFlytek Medical released AI patient management platform 3.0, using the Spark Medical large model to provide out-of-hospital rehabilitation management for discharged patients. Through the collaborative model of AI early warning, manual verification and doctor decision-making, the pain points of post-discharge care, review and risk monitoring of patients are solved. It has been implemented in more than 300 hospitals across the country.

On October 29, Aikang Group released the "2026 Pink Report on Chinese Women's Health" in Chongqing. The report shows that the detection rate of female breast nodules reached 47.06%, an increase of more than 2.5 times compared with 2019, and shows a trend of getting younger. Experts recommend that women over the age of 35 undergo regular screening to reduce the risk of disease through early prevention and early screening.
Well-known health care product brand Swisse has been recalled in Australia due to excessive lead content in two batches of "anti-sugar pills". The brand responded that the products involved did not enter China through general trade, but experts pointed out that there are regulatory blind spots in cross-border e-commerce and purchasing agents channels, and brand trust has been damaged.

The Affiliated Hospital of China Medical University developed the "Bionic Respiratory Dynamic Stretching Culture Platform" to train stem cells by simulating the regular expansion and contraction environment of the lungs to produce exosomes with repair potential to combat pulmonary fibrosis (Caiguabu Lung). The research results have been published in the international journal "Biomaterials".

Since this year, the Ministry of Finance has specially allocated funds to support free influenza vaccination for elderly people aged 65 and above and primary and secondary school students in compulsory education in rural areas. Experts explain vaccination policies, objects, locations and service optimization measures.

Propofol, an anesthetic drug commonly known as the "milk shot", has recently been exposed as being used by clinics to treat insomnia, raising concerns about addiction and safety. Minister of Health and Welfare Shi Chongliang emphasized that propofol cannot be used to treat insomnia, and the Ministry of Health and Welfare does not rule out a comprehensive census to maintain patient safety.